Licensed Practical Nurse in Otway, OH Accepting Medicare

6 Licensed Practical Nurse nurses found. Showing 1 - 6

Virginia Rae Hall, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 207 Davis Rd, Otway, OH 45657 Phone: 740-372-5002

Ms. Veronica Ann Smith, L.P.N. Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2010 Thompson Hill Rd, Otway, OH 45657 Phone: 740-372-2302

Ashley Nichols, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 271 Davis Rd, Otway, OH 45657 Phone: 740-370-8029

Shirley A. Hatten, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 12700 State Route 348, Otway, OH 45657 Phone: 937-587-2353

Mrs. Rebecca Ann Strickland, L.P.N. Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5083 Rarden Hazelbaker Rd, Otway, OH 45657 Phone: 740-372-6709

Linda Marie Hoople, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2242 Mount Hope Rd, Otway, OH 45657 Phone: 740-372-6510

News Archive

ONK Therapeutics and Trinity researchers seek to improve cellular therapies for treating cancer

ONK Therapeutics Ltd, an innovative natural killer (NK) cell therapy company, today announced that it has been awarded an Innovation Partnership Programme grant by Enterprise Ireland (EI) to fund collaborative research at Trinity College Dublin, Ireland, led by Dr. David Finlay to optimize the metabolism and engineering of NK cells for improved cancer therapies.

New robotic system interacts with rehabilitation patients to improve task performance

Researchers from Ben-Gurion University of the Negev in Beer-Sheva, Israel have demonstrated for the first time the feasibility of a robotic system that plays Tic Tac Toe with rehabilitation patients to improve real-life task performance.

Merrimack begins MM-121 Phase 2 combination trial in HER2-negative breast cancer

Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.

Efficacy data of Caldolor Injection in treating fever associated with falciparum malaria published

Cumberland Pharmaceuticals Inc. today announced that data supporting the efficacy of Caldolor in treating fever associated with falciparum malaria was published in the July edition of the peer-reviewed American Journal of Tropical Medicine and Hygiene. The study, which is the first to document an antipyretic effect of an injectable non-steroidal anti-inflammatory drug on fever caused by malaria, demonstrated that patients who received intravenous ibuprofen experienced a greater reduction in their temperatures than those who received placebo.

Scientists identify cellular protein that plays a critical role in Ebola virus infection

Research published by two teams of Army scientists and collaborators has identified a cellular protein that plays a critical role in Ebola virus infection.

Read more Medical News

› Verified 8 days ago